Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong · Delayed Price · Currency is HKD 5.16
-0.07 (-1.34%)
Jul 31, 2026, 4:08 PM HKT
HKG:0512 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, HKG:0512 stock has a consensus rating of "Strong Buy" and an average price target of $11.90. The average 1-year stock price forecast is 130.62% higher than the current stock price, while the lowest is $11.70 (+126.74%) and the highest is $12.00 (+132.56%).
Price Target: $11.90 (+130.62%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Mar 30, 2026.
Analyst Ratings
The average analyst rating for HKG:0512 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 3 | 5 | 5 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 3 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $12.00 | Buy | Maintains | $12.00 | +132.56% | Mar 30, 2026 |
Financial Forecast
Revenue This Year
13.34B
from 12.28B
Increased by 8.60%
Revenue Next Year
14.78B
from 13.34B
Increased by 10.80%
EPS This Year
0.55
from 0.35
Increased by 54.49%
EPS Next Year
0.61
from 0.55
Increased by 10.50%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is HKD.